Abstract:In this study, we evaluated the potential of LiQD cornea glue supplemented with LL37‐derived peptide GF19, delivered through Silicium nanoparticles (SiNP) to prevent herpes simplex virus type 1 (HSV‐1) infection in a rabbit corneal model. SiNP‐GF19 was synthesized using a hydrophobic core, a hydrophilic shell, and a reactive surface that allowed covalent bonding to the collagen‐like peptides of our developed LiQD Cornea glue. Our results showed that SiNP‐GF19 was able to effectively release GF19 in a sustained manner, with approximately 60% of the peptide being released over 24 h. The remaining 40% of GF19 is trapped in the SiNP and can only be released upon complete degradation of the nanoparticles, which may occur via cellular uptake and enzymatic degradation. This ensures the prolonged release of GF19. The mechanism of action of GF19 against HSV‐1 may involve preventing the binding of the virus to host cells. Previous studies have shown that LL37, from which GF19 is derived, can block HSV‐1 binding to host cells, leading to decreased viral infection. However, in our study, we did not see reduced viral shedding, furthermore, nanoparticles coated with the GF19 peptide or nanoparticles themselves may have an eye irritant effect. Nevertheless, LiQD Cornea supplemented with SiNP‐GF19 or LiQD alone were effective in promoting corneal regeneration and healing. Specifically, it led to the formation of a relatively mature epithelium composed of 2–3 epithelial layers, expressing CK3 in the outermost epithelial layer, compared to the absence of epithelium or a monolayer of unstructured CK3‐negative epithelium in the cyanoacrylate adhesive control group. LiQD Cornea formulation without SiNP‐GF19 also displayed significantly lower α‐SMA staining than the rest of the experimental groups in the implant area, which overexpression is associated with abnormal extracellular matrix deposition and scar formation. In terms of nerve regeneration, all LiQD Cornea formulations showed βIII tubulin expression, indicating immature neuronal microtubule structures. In summary, all three experimental treatment strategies were significantly more effective compared to the cyanoacrylate adhesive control group, significantly smaller scar tissues without ingrown vascular networks were formed, though, only mild antiviral properties of SiNP‐GF19 were observed.

Modified host defence peptide GF19 slows TNT-mediated spread of corneal herpes simplex virus serotype I infection

Cationic human defence peptides and cornea HSV ‐1 infections: Results of a rabbit study

Meganuclease targeting HSV-1 protects against herpetic keratitis: Application to corneal transplants

Targeting NECTIN-1 Based on CRISPR/Cas9 System Attenuated the Herpes Simplex Virus Infection in Human Corneal Epithelial Cells In Vitro

A Supramolecular Gel with Unique Rheological Properties for Treating Corneal Virus Infection

Corneal toxicity of cell-penetrating peptides that inhibit Herpes simplex virus entry

High-level expression of glycoprotein D by a dominant-negative HSV-1 virus augments its efficacy as a vaccine against HSV-1 infection.

Phosphorylcholine and KR12-Containing Corneal Implants in HSV-1-Infected Rabbit Corneas

Targeted delivery of herpes simplex virus glycoprotein D to CD169+ macrophages using ganglioside liposomes alleviates herpes simplex keratitis in mice

Therapeutic effects and related mechanisms of nerve growth factor on herpes simplex virus keratitis

Single AAV-Mediated CRISPR-SaCas9 Inhibits HSV-1 Replication by Editing ICP4 in Trigeminal Ganglion Neurons

A novel GFP-based strategy to quantitate cellular spatial associations in HSV-1 viral pathogenesis

Intracorneal delivery of HSV-targeting CRISPR/Cas9 mRNA prevents herpetic stromal keratitis

Nanoparticle ocular immunotherapy for herpesvirus surface eye infections evaluated in cat infection model

Rapid NETosis Is an Effector Mechanism to Combat Ocular Herpes Infection

Inhibitory Effects of Tranilast on Cytokine, Chemokine, Adhesion Molecule, and Matrix Metalloproteinase Expression in Human Corneal Fibroblasts Exposed to Poly(I:C)

A Dual Role for Corneal Dendritic Cells in Herpes Simplex Keratitis: Local Suppression of Corneal Damage and Promotion of Systemic Viral Dissemination

Functional Peptide-Loaded Gelatin Nanoparticles as Eyedrops for Cornea Neovascularization Treatment

Herpes Virus Entry Mediator in Human Corneal Epithelial Cells Modulates the Production of Inflammatory Cytokines in Response to Hsv Type 1 Challenge

Adenovirus-mediated RNA interference against herpes simplex virus infection in vitro

Targeting herpes simplex virus with CRISPR–Cas9 cures herpetic stromal keratitis in mice